vs
Fortune Brands Innovations, Inc.（FBIN）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Fortune Brands Innovations, Inc.的季度营收约是Revvity的1.4倍（$1.1B vs $772.1M），Revvity净利率更高（12.7% vs 7.1%，领先5.7%），Revvity同比增速更快（5.9% vs -2.4%），Fortune Brands Innovations, Inc.自由现金流更多（$183.7M vs $161.8M），过去两年Revvity的营收复合增速更高（9.0% vs -1.5%）
Fortune Brands Innovations是美国家居及安防产品生产商，总部位于伊利诺伊州迪尔菲尔德，位列财富500强及标普400指数。旗下拥有摩恩、House of Rohl、玛斯特锁等知名品牌，业务覆盖厨卫、户外用品、安防、橱柜制造等领域，2021年底全球员工约2.8万人。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FBIN vs RVTY — 直观对比
营收规模更大
FBIN
是对方的1.4倍
$772.1M
营收增速更快
RVTY
高出8.3%
-2.4%
净利率更高
RVTY
高出5.7%
7.1%
自由现金流更多
FBIN
多$21.9M
$161.8M
两年增速更快
RVTY
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $772.1M |
| 净利润 | $76.3M | $98.4M |
| 毛利率 | 43.8% | — |
| 营业利润率 | 11.3% | 14.5% |
| 净利率 | 7.1% | 12.7% |
| 营收同比 | -2.4% | 5.9% |
| 净利润同比 | -27.3% | 3.9% |
| 每股收益（稀释后） | $0.63 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBINRVTY
| Q4 25 | $1.1B | $772.1M | ||
| Q3 25 | $1.1B | $698.9M | ||
| Q2 25 | $1.2B | $720.3M | ||
| Q1 25 | $1.0B | $664.8M | ||
| Q4 24 | $1.1B | $729.4M | ||
| Q3 24 | $1.2B | $684.0M | ||
| Q2 24 | $1.2B | $691.7M | ||
| Q1 24 | $1.1B | $649.9M |
净利润FBINRVTY
| Q4 25 | $76.3M | $98.4M | ||
| Q3 25 | $70.8M | $46.7M | ||
| Q2 25 | $100.3M | $53.9M | ||
| Q1 25 | $51.4M | $42.2M | ||
| Q4 24 | $105.0M | $94.6M | ||
| Q3 24 | $136.6M | $94.4M | ||
| Q2 24 | $133.9M | $55.4M | ||
| Q1 24 | $96.4M | $26.0M |
毛利率FBINRVTY
| Q4 25 | 43.8% | — | ||
| Q3 25 | 45.2% | 53.6% | ||
| Q2 25 | 45.1% | 54.5% | ||
| Q1 25 | 44.0% | 56.5% | ||
| Q4 24 | 46.0% | — | ||
| Q3 24 | 45.9% | 56.3% | ||
| Q2 24 | 43.6% | 55.7% | ||
| Q1 24 | 43.9% | 54.6% |
营业利润率FBINRVTY
| Q4 25 | 11.3% | 14.5% | ||
| Q3 25 | 11.0% | 11.7% | ||
| Q2 25 | 14.3% | 12.6% | ||
| Q1 25 | 9.4% | 10.9% | ||
| Q4 24 | 16.1% | 16.3% | ||
| Q3 24 | 17.8% | 14.3% | ||
| Q2 24 | 16.1% | 12.4% | ||
| Q1 24 | 14.0% | 6.8% |
净利率FBINRVTY
| Q4 25 | 7.1% | 12.7% | ||
| Q3 25 | 6.2% | 6.7% | ||
| Q2 25 | 8.3% | 7.5% | ||
| Q1 25 | 5.0% | 6.4% | ||
| Q4 24 | 9.5% | 13.0% | ||
| Q3 24 | 11.8% | 13.8% | ||
| Q2 24 | 10.8% | 8.0% | ||
| Q1 24 | 8.7% | 4.0% |
每股收益（稀释后）FBINRVTY
| Q4 25 | $0.63 | $0.86 | ||
| Q3 25 | $0.59 | $0.40 | ||
| Q2 25 | $0.83 | $0.46 | ||
| Q1 25 | $0.42 | $0.35 | ||
| Q4 24 | $0.84 | $0.77 | ||
| Q3 24 | $1.09 | $0.77 | ||
| Q2 24 | $1.06 | $0.45 | ||
| Q1 24 | $0.76 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $264.0M | $919.9M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.4B | $7.3B |
| 总资产 | $6.5B | $12.2B |
| 负债/权益比越低杠杆越低 | 1.07× | — |
8季度趋势，按日历期对齐
现金及短期投资FBINRVTY
| Q4 25 | $264.0M | $919.9M | ||
| Q3 25 | $223.9M | $931.4M | ||
| Q2 25 | $234.7M | $991.8M | ||
| Q1 25 | $340.0M | $1.1B | ||
| Q4 24 | $381.1M | $1.2B | ||
| Q3 24 | $344.8M | $1.2B | ||
| Q2 24 | $352.6M | $2.0B | ||
| Q1 24 | $359.7M | $1.7B |
总债务FBINRVTY
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益FBINRVTY
| Q4 25 | $2.4B | $7.3B | ||
| Q3 25 | $2.4B | $7.4B | ||
| Q2 25 | $2.3B | $7.6B | ||
| Q1 25 | $2.3B | $7.6B | ||
| Q4 24 | $2.4B | $7.7B | ||
| Q3 24 | $2.4B | $7.9B | ||
| Q2 24 | $2.3B | $7.9B | ||
| Q1 24 | $2.3B | $7.8B |
总资产FBINRVTY
| Q4 25 | $6.5B | $12.2B | ||
| Q3 25 | $6.5B | $12.1B | ||
| Q2 25 | $6.6B | $12.4B | ||
| Q1 25 | $6.6B | $12.4B | ||
| Q4 24 | $6.6B | $12.4B | ||
| Q3 24 | $6.6B | $12.8B | ||
| Q2 24 | $6.7B | $13.4B | ||
| Q1 24 | $6.8B | $13.4B |
负债/权益比FBINRVTY
| Q4 25 | 1.07× | — | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 1.16× | — | ||
| Q4 24 | 1.10× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.17× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $208.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $183.7M | $161.8M |
| 自由现金流率自由现金流/营收 | 17.0% | 21.0% |
| 资本支出强度资本支出/营收 | 2.3% | 2.6% |
| 现金转化率经营现金流/净利润 | 2.73× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $366.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流FBINRVTY
| Q4 25 | $208.2M | $182.0M | ||
| Q3 25 | $204.4M | $138.5M | ||
| Q2 25 | $149.4M | $134.3M | ||
| Q1 25 | $-83.4M | $128.2M | ||
| Q4 24 | $272.3M | $174.2M | ||
| Q3 24 | $205.3M | $147.9M | ||
| Q2 24 | $261.5M | $158.6M | ||
| Q1 24 | $-71.3M | $147.6M |
自由现金流FBINRVTY
| Q4 25 | $183.7M | $161.8M | ||
| Q3 25 | $177.0M | $120.0M | ||
| Q2 25 | $118.7M | $115.5M | ||
| Q1 25 | $-112.6M | $112.2M | ||
| Q4 24 | $212.1M | $149.8M | ||
| Q3 24 | $175.6M | $125.6M | ||
| Q2 24 | $222.7M | $136.6M | ||
| Q1 24 | $-135.9M | $129.7M |
自由现金流率FBINRVTY
| Q4 25 | 17.0% | 21.0% | ||
| Q3 25 | 15.4% | 17.2% | ||
| Q2 25 | 9.9% | 16.0% | ||
| Q1 25 | -10.9% | 16.9% | ||
| Q4 24 | 19.2% | 20.5% | ||
| Q3 24 | 15.2% | 18.4% | ||
| Q2 24 | 18.0% | 19.7% | ||
| Q1 24 | -12.2% | 20.0% |
资本支出强度FBINRVTY
| Q4 25 | 2.3% | 2.6% | ||
| Q3 25 | 2.4% | 2.6% | ||
| Q2 25 | 2.6% | 2.6% | ||
| Q1 25 | 2.8% | 2.4% | ||
| Q4 24 | 5.5% | 3.4% | ||
| Q3 24 | 2.6% | 3.3% | ||
| Q2 24 | 3.1% | 3.2% | ||
| Q1 24 | 5.8% | 2.7% |
现金转化率FBINRVTY
| Q4 25 | 2.73× | 1.85× | ||
| Q3 25 | 2.89× | 2.97× | ||
| Q2 25 | 1.49× | 2.49× | ||
| Q1 25 | -1.62× | 3.03× | ||
| Q4 24 | 2.59× | 1.84× | ||
| Q3 24 | 1.50× | 1.57× | ||
| Q2 24 | 1.95× | 2.87× | ||
| Q1 24 | -0.74× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBIN
| Wholesale Retail Trade | $526.7M | 49% |
| Home Center Retailer | $257.1M | 24% |
| Security Segment | $165.8M | 15% |
| Other Retailer | $118.2M | 11% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
